These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 10894262)
1. Knock-out mouse for Canavan disease: a model for gene transfer to the central nervous system. Matalon R; Rady PL; Platt KA; Skinner HB; Quast MJ; Campbell GA; Matalon K; Ceci JD; Tyring SK; Nehls M; Surendran S; Wei J; Ezell EL; Szucs S J Gene Med; 2000; 2(3):165-75. PubMed ID: 10894262 [TBL] [Abstract][Full Text] [Related]
2. Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan disease. Klugmann M; Leichtlein CB; Symes CW; Serikawa T; Young D; During MJ Mol Ther; 2005 May; 11(5):745-53. PubMed ID: 15851013 [TBL] [Abstract][Full Text] [Related]
3. A mutation of aspartoacylase gene in a Turkish patient with Canavan disease. Eke GH; Iscan A; Cece H; Calik M Genet Couns; 2012; 23(1):9-12. PubMed ID: 22611636 [TBL] [Abstract][Full Text] [Related]
4. Effects of AAV-2-mediated aspartoacylase gene transfer in the tremor rat model of Canavan disease. McPhee SW; Francis J; Janson CG; Serikawa T; Hyland K; Ong EO; Raghavan SS; Freese A; Leone P Brain Res Mol Brain Res; 2005 Apr; 135(1-2):112-21. PubMed ID: 15857674 [TBL] [Abstract][Full Text] [Related]
5. Aspartoacylase gene knockout in the mouse: impact on reproduction. Surendran S; Szucs S; Tyring SK; Matalon R Reprod Toxicol; 2005; 20(2):281-3. PubMed ID: 15907664 [TBL] [Abstract][Full Text] [Related]
6. Canavan disease: a review of recent developments. Gordon N Eur J Paediatr Neurol; 2001; 5(2):65-9. PubMed ID: 11589315 [TBL] [Abstract][Full Text] [Related]
7. Canavan disease: genomic organization and localization of human ASPA to 17p13-ter and conservation of the ASPA gene during evolution. Kaul R; Balamurugan K; Gao GP; Matalon R Genomics; 1994 May; 21(2):364-70. PubMed ID: 8088831 [TBL] [Abstract][Full Text] [Related]
8. Canavan disease and the role of N-acetylaspartate in myelin synthesis. Namboodiri AM; Peethambaran A; Mathew R; Sambhu PA; Hershfield J; Moffett JR; Madhavarao CN Mol Cell Endocrinol; 2006 Jun; 252(1-2):216-23. PubMed ID: 16647192 [TBL] [Abstract][Full Text] [Related]
9. Adeno-associated virus-mediated aspartoacylase gene transfer to the brain of knockout mouse for canavan disease. Matalon R; Surendran S; Rady PL; Quast MJ; Campbell GA; Matalon KM; Tyring SK; Wei J; Peden CS; Ezell EL; Muzyczka N; Mandel RJ Mol Ther; 2003 May; 7(5 Pt 1):580-7. PubMed ID: 12718900 [TBL] [Abstract][Full Text] [Related]
10. Novel mutation of aspartoacylase gene in a Turkish patient with Canavan disease. Unalp A; Altiok E; Uran N; Oztürk A; Yüksel S J Trop Pediatr; 2008 Jun; 54(3):208-10. PubMed ID: 17999961 [TBL] [Abstract][Full Text] [Related]
11. Aspartoacylase gene knockout results in severe vacuolation in the white matter and gray matter of the spinal cord in the mouse. Surendran S; Campbell GA; Tyring SK; Matalon R Neurobiol Dis; 2005 Mar; 18(2):385-9. PubMed ID: 15686967 [TBL] [Abstract][Full Text] [Related]
12. Mouse neural progenitor cells differentiate into oligodendrocytes in the brain of a knockout mouse model of Canavan disease. Surendran S; Shihabuddin LS; Clarke J; Taksir TV; Stewart GR; Parsons G; Yang W; Tyring SK; Michals-Matalon K; Matalon R Brain Res Dev Brain Res; 2004 Oct; 153(1):19-27. PubMed ID: 15464214 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical localization of aspartoacylase in the rat central nervous system. Madhavarao CN; Moffett JR; Moore RA; Viola RE; Namboodiri MA; Jacobowitz DM J Comp Neurol; 2004 May; 472(3):318-29. PubMed ID: 15065127 [TBL] [Abstract][Full Text] [Related]
14. Possible genotype-phenotype correlations in children with mild clinical course of Canavan disease. Tacke U; Olbrich H; Sass JO; Fekete A; Horvath J; Ziyeh S; Kleijer WJ; Rolland MO; Fisher S; Payne S; Vargiami E; Zafeiriou DI; Omran H Neuropediatrics; 2005 Aug; 36(4):252-5. PubMed ID: 16138249 [TBL] [Abstract][Full Text] [Related]
15. Canavan disease: studies on the knockout mouse. Matalon R; Michals-Matalon K; Surendran S; Tyring SK Adv Exp Med Biol; 2006; 576():77-93; discussion 361-3. PubMed ID: 16802706 [TBL] [Abstract][Full Text] [Related]
16. Atypical MRI findings in Canavan disease: a patient with a mild course. Yalcinkaya C; Benbir G; Salomons GS; Karaarslan E; Rolland MO; Jakobs C; van der Knaap MS Neuropediatrics; 2005 Oct; 36(5):336-9. PubMed ID: 16217711 [TBL] [Abstract][Full Text] [Related]
17. Lack of aspartoacylase activity disrupts survival and differentiation of neural progenitors and oligodendrocytes in a mouse model of Canavan disease. Kumar S; Biancotti JC; Matalon R; de Vellis J J Neurosci Res; 2009 Nov; 87(15):3415-27. PubMed ID: 19739253 [TBL] [Abstract][Full Text] [Related]
18. Canavan disease: a white matter disorder. Kumar S; Mattan NS; de Vellis J Ment Retard Dev Disabil Res Rev; 2006; 12(2):157-65. PubMed ID: 16807907 [TBL] [Abstract][Full Text] [Related]
19. Nur7 is a nonsense mutation in the mouse aspartoacylase gene that causes spongy degeneration of the CNS. Traka M; Wollmann RL; Cerda SR; Dugas J; Barres BA; Popko B J Neurosci; 2008 Nov; 28(45):11537-49. PubMed ID: 18987190 [TBL] [Abstract][Full Text] [Related]
20. Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy. von Jonquieres G; Spencer ZHT; Rowlands BD; Klugmann CB; Bongers A; Harasta AE; Parley KE; Cederholm J; Teahan O; Pickford R; Delerue F; Ittner LM; Fröhlich D; McLean CA; Don AS; Schneider M; Housley GD; Rae CD; Klugmann M Acta Neuropathol; 2018 Jan; 135(1):95-113. PubMed ID: 29116375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]